CoChat

In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy

The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.

Abstract

Although the current clinical formulation of paclitaxel (Taxol) has a promising clinical activity against a wide variety of tumors, it has significant toxic side effects, some of which are associated with its formulation in a 1:1 (v/v) mixture of Cremophor EL and dehydrated alcohol. One of the problems associated with the intravenous administration of paclitaxel is its low solubility in water. Our study was designed to evaluate the pharmacokinetics, tissue distribution, toxicity and efficacy of a paclitaxel (Genexol)-containing biodegradable polymeric micellar system (Genexol-PM) in comparison to Taxol. Genexol-PM was newly developed by using a low molecular weight, nontoxic and biodegradable amphiphilic diblock copolymer, monomethoxy poly(ethylene glycol)-block-poly(D,L-lactide) (mPEG-PDLLA) and paclitaxel (Genexol, Samyang Genex Co., Seoul, Korea). In a human cancer cell line model, Genexol-PM and Taxol showed comparable in vitro cytotoxicity against human ovarian cancer cell line OVCAR-3 and human breast cancer cell line MCF7. The maximum tolerated dose (MTD) of Genexol-PM and Taxol in nude mice was determined to be 60 and 20 mg/kg, respectively. The median lethal dose (LD(50)) in Sprague--Dawley rats was 205.4 mg/kg (male) and 221.6 mg/kg (female) for Genexol-PM, while 8.3 mg/kg (male) and 8.8 mg/kg (female) for Taxol. After intravenous administration of Genexol-PM in murine B16 melanoma-induced female SPF C57BL/6 mice at a dose of 50 mg/kg, the area under the plasma conc…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0168-3659(01)00275-9

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 74 references

Research works printed but not linked: 3

  1. 1993, Paclitaxel (Taxol) for ovarian cancer, Med. Lett. Drugs Ther., 35, 39
  2. Kramer, 1995, Paclitaxel pharmaceutical and pharmacological issues, Eur. Hosp. Pharm., 1, 37
  3. Presenti, 1995, Synthesis and biological activity of water soluble polymer-bound Taxol derivatives, Proc. Am. Assoc. Cancer Res., 36, 307

Cited by

See all 745

Metadata

Authors
Kim, S. C., Kim, D. W., Shim, Y. H., Bang, J. S., Oh, H. S., Kim, S. W., & Seo, M. H.
Affiliations
University of Utah (US)
Corresponding author
Seo, Min Hyo
Venue
Journal of Controlled Release
Publisher
Elsevier BV
Published
2001-05
Volume
72
Issue
1-3
Pages
191-202
ISSN
0168-3659 (ISSN-L)
OpenAlex
W2032860131
Cited by
734
References
74
Citations by year
2026: 12 · 2025: 30 · 2024: 33 · 2023: 35 · 2022: 30 · 2021: 24 · 2020: 39 · 2019: 29 · 2018: 35 · 2017: 38 · 2016: 51 · 2015: 50 · 2014: 40 · 2013: 47 · 2012: 33
FWCI
5.12
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Journal of Controlled Release (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Keywords
paclitaxel, polymeric micelles, drug toxicity, pharmacokinetics, tissue distribution, antitumor efficacy, ovarian cancer, breast cancer, B16 melanoma, maximum tolerated dose, cytotoxicity
MeSH terms
Polylactic Acid-Polyglycolic Acid Copolymer, Animals, Antineoplastic Agents, Phytogenic, Drug Carriers, Drug Compounding, Female, Humans, Lethal Dose 50, Male, Mice, Nude, Micelles, Polyethylene Glycols, Polyglycolic Acid, Polymers, Tissue Distribution, Tumor Cells, Cultured, Rats, Sprague-Dawley, Paclitaxel, Lactic Acid, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. https://app.cochat.ai/papers/10.1016/s0168-3659(01)00275-9
The paper
Kim, S. C., Kim, D. W., Shim, Y. H., Bang, J. S., Oh, H. S., Kim, S. W., & Seo, M. H. (2001). In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. Journal of Controlled Release. https://doi.org/10.1016/s0168-3659(01)00275-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.